Why is this woman smiling? The hard sell of bad medicine.
Bloice
Carl
C
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000329:Advertising / Q000191:economics / Q000331:legislation & jurisprudence / Q000379:methods*; D000897:Anti-Ulcer Agents / Q000191:economics; D016861:Cyclooxygenase Inhibitors / Q000191:economics; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007783:Lactones / Q000009:adverse effects; D064747:Lansoprazole; D040541:Marketing / Q000379:methods; D009853:Omeprazole / Q000031:analogs & derivatives / Q000191:economics; D004364:Pharmaceutical Preparations / Q000191:economics; D013450:Sulfones / Q000009:adverse effects
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D004364:Pharmaceutical Preparations; D013450:Sulfones; D064747:Lansoprazole; C116926:rofecoxib; D009853:Omeprazole